Page results
-
There’s a lot of information available out there. Here you can find information about type 1 and type 2 diabetes.
-
Patient story - Zehavah Handler - When sleep becomes a nightmare. Zehavah Handler struggled to sleep for 25 years before completing a five-week course at UCLH’s insomnia clinic. Here, she tells us how it changed her life.
-
Information about having a gadolinium-based contrast agent for MRI examinations while breastfeeding.
-
Emma, our support and information specialist, gives tips to overcome loneliness.
-
This page explains what parathyroid surgery is and gives some information about what it involves.
-
The department undertakes specialist dental treatment for those under 16 years of age ( 15 years and 11 months), and deals with the aetiology, prevention, diagnosis and treatment of oral disorders; mouth conditions and teeth of children.
-
UCLH today marks International Clinical Trials Day, which this year coincides with the National Institute for Health Research (NIHR) campaign encouraging everyone to ‘Be Part of Research.’
-
This information has been developed by the welfare and benefits team based in the Macmillan Support and Information Service. It outlines the most common benefits available.
-
This page provides information on transperineal biopsies of the prostate.
-
Information about the Integrated General Medicine Service at the RLHIM patient information leaflet.
File results
-
FOI/2024/0097 - Laboratory Information Management System (LIMS)/ pathology IT system
-
FOI/2024/0101 - Immunoglobulin drug treatments
-
FOI/2024/0108 - Clinical letters/ EPR, PAS, patient portal systems, hybrid mail contract
-
FOI/2024/0112 - Fertility treatment in 2021
-
FOI/2024/0116 - Patient treatment due to noise levels of the London Underground
-
FOI/2024/0121 - Migraine treatments
-
FOI/2024/0126 - Ophthalmology RTT pathway
-
FOI/2024/0128 - Post mortem cardiac device interrogation
-
FOI/2024/0129 - Nursing associate and anaesthesia associate staffing
-
FOI/2024/0131 - Alpha-1 Proteinase-Inhibitor (AAT) purchased in 2023